The pathogenic role of annexin-V in the antiphospholipid syndrome.

J. H. Rand

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


The antiphospholipid antibody syndrome is an autoimmune condition in which venous or arterial thrombosis and recurrent pregnancy losses occur in patients having serologic evidence of antibodies against anionic phospholipid-protein complexes. The pathophysiologic mechanisms of this syndrome have not yet been established. Annexin-V, an anionic phospholipid-binding protein with potent anticoagulant activity, is necessary for maintenance of placental integrity and may play a thromboregulatory role at the vascular-blood interface by forming two-dimensional crystals which shield anionic phospholipids from complexing with coagulation proteins from circulating blood. We propose that thrombosis and pregnancy loss in the antiphospholipid syndrome may be caused by disruption of this Annexin-V shield by antiphospholipid (and cofactor) antibodies, thereby increasing the net quantity of thrombogenic phospholipids exposed to the circulating blood. The data accumulated from tissue immunohistochemistry, trophoblast and endothelial cell culture studies, coagulation studies using noncellular phospholipids, and competition studies on artificial phospholipid bilayer are consistent with the hypothesis that interference with the binding of Annexin-V to anionic phospholipid surfaces is an important mechanism of thrombosis and pregnancy loss in the antiphospholipid syndrome.

Original languageEnglish
Pages (from-to)246-251
Number of pages6
JournalCurrent Rheumatology Reports
Issue number3
StatePublished - Jun 2000


Dive into the research topics of 'The pathogenic role of annexin-V in the antiphospholipid syndrome.'. Together they form a unique fingerprint.

Cite this